As of Dec 31, 2024, Quest Diagnostics Incorporated's fair value using the Ben Graham formula is $287.7 per share. This is calculated using Ben Graham formula, where EPS is $7.8 and BVPS (Book Value Per Share) is $60.3. The current price of $162.5 suggests Quest Diagnostics Incorporated may be overvalued by this conservative metric.
Quest Diagnostics Incorporated earnings per share (EPS) for the twelve months ending Dec 31, 2024, was $7.8, a 17.3% growth year-over-year.
Quest Diagnostics Incorporated's margin of safety is positive 77.1%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.